Patents by Inventor Anthony West
Anthony West has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 12285426Abstract: A method of treating and attenuating L-DOPA-induced dyskinesia, comprising administering an effective dose of at least one pharmacological agent, e.g., vilazodone, having serotonin-specific reuptake inhibition (SSRI) and serotonin receptor 1A (5-HT1AR) partial agonism activity, in conjunction with L-DOPA. Other agents, such as an L-DOPA decarboxylase inhibitor, e.g., carbidopa, or other adjunct treatments may also be provided.Type: GrantFiled: April 26, 2021Date of Patent: April 29, 2025Assignees: The Research Foundation for The State University of New York, Rosalind Franklin University of Medicine and Science, Board of Trustees of Michigan State UniversityInventors: Christopher Roy Bishop, Anthony West, Fredric Manfredsson
-
Publication number: 20220360062Abstract: A flush-mounted cover apparatus is provided for electrical and other components mounted in a structure, such as a wall, floor or ceiling. The cover apparatus includes a main body with a hollow interior receiving the component. The main body includes an outer lip with perforations. A locking mechanism secures the main body in the structure. A fitting system accommodates adjusting the cover apparatus position relative to the structure surface for flush-mounting. An outer plate is mounted on the main body and provides access thereto. A finish guard is configured for mounting on the outer plate.Type: ApplicationFiled: May 6, 2022Publication date: November 10, 2022Inventors: Anthony West, Andrea Petti
-
Publication number: 20210393621Abstract: A method of treating and attenuating L-DOPA-induced dyskinesia, comprising administering an effective dose of at least one pharmacological agent, e.g., vilazodone, having serotonin-specific reuptake inhibition (SSRI) and serotonin receptor 1A (5-HT1AR) partial agonism activity, in conjunction with L-DOPA. Other agents, such as an L-DOPA decarboxylase inhibitor, e.g., carbidopa, or other adjunct treatments may also be provided.Type: ApplicationFiled: October 25, 2019Publication date: December 23, 2021Inventors: Christopher Roy Bishop, Anthony West, Fredric Manfresson
-
Publication number: 20210346372Abstract: A method of treating and attenuating L-DOPA-induced dyskinesia, comprising administering an effective dose of at least one pharmacological agent, e.g., vilazodone, having serotonin-specific reuptake inhibition (SSRI) and serotonin receptor 1A (5-HT1AR) partial agonism activity, in conjunction with L-DOPA. Other agents, such as an L-DOPA decarboxylase inhibitor, e.g., carbidopa, or other adjunct treatments may also be provided.Type: ApplicationFiled: April 26, 2021Publication date: November 11, 2021Inventors: Christopher Roy Bishop, Anthony West, Fredric Manfresson
-
Patent number: 8735062Abstract: This invention relates to the detection and quantitation of target nucleic acids in a heterogeneous mixture in a sample and the methods of use thereof. The detection system includes a chemiluminescent molecule, a chemiluminescent substrate, a dye that is light responsive when intercalated into nucleic acids and nucleic acids. This invention is useful in any application where detection of a specific nucleic acid sequence is desirable, or where the detection of enzymes that modify nucleic acids is desirable such as diagnostics, research uses and industrial applications.Type: GrantFiled: December 11, 2012Date of Patent: May 27, 2014Assignee: Beacon Biotechnology LLCInventors: Anthony West, Millard Gambrell Cull
-
Publication number: 20130304023Abstract: A fabric medical device and method of making the device can include warp yarns and fill yarns woven together to form a first tubular extent having a first diameter, a second tubular extent having a second diameter, and a transition tubular extent having a graduated diameter between the first and second tubular extents. A tapered edge can be formed along the transition tubular extent by weaving such that a graduated number of warp yarns are disengaged along the transition tubular extent. A seam can be woven along the tapered edge that is configured to provide a substantially fluid-tight transition between the first and second tubular extents. The device can further include the warp yarns in at least the transition tubular extent having a tenacity higher than the tenacity of the fill yarns. The device can be a bone filler delivery device adapted to deliver bone filler in an internal body region.Type: ApplicationFiled: June 11, 2013Publication date: November 14, 2013Inventors: Peter Schmitt, Anthony West, John Greco, Stephanie Booz Norris
-
Patent number: 8329397Abstract: This invention relates to the detection and quantitation of target nucleic acids in a heterogeneous mixture in a Sample and the methods of use thereof. The detection system includes a chemiluminescent molecule, a chemiluminescent substrate, a dye that is light responsive when intercalated into nucleic acids and nucleic acids. This invention is useful in any application where detection of a specific nucleic acid sequence is desirable, or where the detection of enzymes that modify nucleic acids is desirable such as diagnostics, research uses and industrial applications.Type: GrantFiled: June 5, 2006Date of Patent: December 11, 2012Assignee: Beacon Biotechnology Inc.Inventors: Anthony West, Millard Gambrell Cull
-
Patent number: 7862604Abstract: A bifurcated graft is formed from a series of individual components which are intraluminally delivered apart from one another and then assembled to form a fully supported structure. The modular system includes a base member and one or more grafts connected thereto. The base member preferably includes a portion which gradually increases in diameter. A tubular device for inserting the components of the modular system and a method employing the modular system for repairing an abdominal aortic aneurysm are also disclosed.Type: GrantFiled: February 5, 2001Date of Patent: January 4, 2011Assignee: Endovascular Technologies, Inc.Inventors: Jean Paul Marcade, Anthony West, Frederick W. Kornahrens
-
Publication number: 20100221703Abstract: This invention relates to the detection and quantitation of target nucleic acids in a heterogeneous mixture in a Sample and the methods of use thereof. The detection system includes a chemiluminescent molecule, a chemiluminescent substrate, a dye that is light responsive when intercalated into nucleic acids and nucleic acids. This invention is useful in any application where detection of a specific nucleic acid sequence is desirable, or where the detection of enzymes that modify nucleic acids is desirable such as diagnostics, research uses and industrial applications.Type: ApplicationFiled: June 5, 2006Publication date: September 2, 2010Applicant: Blind Pig Proteomics, Inc.Inventors: Anthony West, Millard Gambrell Cull
-
Publication number: 20090088337Abstract: Compositions and methods for Resonance Energy Transfer (RET) Based Detection of analyte binding are provided.Type: ApplicationFiled: October 17, 2008Publication date: April 2, 2009Inventors: Ronald Gill, Miles Brennan, Millard Gambrell Cull, Anthony West
-
Publication number: 20080300602Abstract: A fabric medical device and method of making the device can include warp yarns and fill yarns woven together to form a first tubular extent having a first diameter, a second tubular extent having a second diameter, and a transition tubular extent having a graduated diameter between the first and second tubular extents. A tapered edge can be formed along the transition tubular extent by weaving such that a graduated number of warp yarns are disengaged along the transition tubular extent. A seam can be woven along the tapered edge that is configured to provide a substantially fluid-tight transition between the first and second tubular extents. The device can further include the warp yarns in at least the transition tubular extent having a tenacity higher than the tenacity of the fill yarns. The device can be a bone filler delivery device adapted to deliver bone filler in an internal body region.Type: ApplicationFiled: March 3, 2008Publication date: December 4, 2008Inventors: Peter J. Schmitt, Anthony West, John George Greco, Stephanie Booz Norris
-
Patent number: 6964679Abstract: A bifurcated graft is formed from a series of individual components which are intraluminally delivered apart from one another and then assembled to form a fully supported structure. The modular system includes a base member and one or more grafts connected thereto. The base member preferably includes a portion which gradually increases in diameter. A tubular device for inserting the components of the modular system and a method employing the modular system for repairing an abdominal aortic aneurysm are also disclosed.Type: GrantFiled: September 6, 2002Date of Patent: November 15, 2005Assignee: Endovascular Technologies, Inc.Inventors: Jean Paul Marcade, Anthony West, Frederick W. Kornahrens
-
Patent number: 6660033Abstract: A bifurcated graft is formed from a series of individual components which are intraluminally delivered apart from one another and then assembled to form a fully supported structure. The modular system includes a base member and one or more crafts connected thereto. The base member preferably includes a portion which gradually increases in diameter. A tubular device for inserting the components of the modular system and a method employing the modular system for repairing an abdominal aortic aneurysm are also disclosed.Type: GrantFiled: July 1, 2002Date of Patent: December 9, 2003Assignee: Endovascular Technologies, Inc.Inventors: Jean Paul Marcade, Anthony West, Frederick W. Kornahrens
-
Patent number: 6592615Abstract: A bifurcated graft is formed from a series of individual components which are intraluminally delivered apart from one another and then assembled to form a fully supported structure. The modular system includes a base member and one or more grafts connected thereto. The base member preferably includes a portion which gradually increases in diameter. A tubular device for inserting the components of the modular system and a method employing the modular system for repairing an abdominal aortic aneurysm are also disclosed.Type: GrantFiled: February 5, 2001Date of Patent: July 15, 2003Assignee: Endovascular Technologies, Inc.Inventors: Jean Paul Marcade, Anthony West, Frederick W. Kornahrens
-
Patent number: 6464721Abstract: A bifurcated graft is formed from a series of individual components which are intraluminally delivered apart from one another and then assembled to form a fully supported structure. The modular system includes a base member and one or more grafts connected thereto. The base member preferably includes a portion which gradually increases in diameter. A tubular device for inserting the components of the modular system and a method employing the modular system for repairing an abdominal aortic aneurysm are also disclosed.Type: GrantFiled: August 18, 2000Date of Patent: October 15, 2002Assignee: Endovascular Technologies, Inc.Inventors: Jean Paul Marcade, Anthony West, Frederick W. Kornahrens
-
Patent number: 6416542Abstract: A bifurcated graft is formed from a series of individual components which are intraluminally delivered apart from one another and then assembled to form a fully supported structure. The modular system includes a base member and one or more grafts connected thereto. The base member preferably includes a portion which gradually increases in diameter. A tubular device for inserting the components of the modular system and a method employing the modular system for repairing an abdominal aortic aneurysm are also disclosed.Type: GrantFiled: August 3, 1999Date of Patent: July 9, 2002Assignee: Endovascular Technologies, Inc.Inventors: Jean Paul Marcade, Anthony West, Frederick W. Kornahrens
-
Patent number: 5993481Abstract: A bifurcated graft is formed from a series of individual components which are intraluminally delivered apart from one another and then assembled to form a fully supported structure. The modular system includes a base member and one or more grafts connected thereto. The base member preferably includes a portion which gradually increases in diameter. A tubular device for inserting the components of the modular system and a method employing the modular system for repairing an abdominal aortic aneurysm are also disclosed.Type: GrantFiled: April 29, 1997Date of Patent: November 30, 1999Assignee: InterVascular, Inc.Inventors: Jean Paul Marcade, Anthony West, Frederick W. Kornahrens